Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

2022studies shown

Showing 626-650 of 2,022

RecruitingISRCTN72416821

Modernising teams service delivery: implementing the NICE schizophrenia guideline

This study is looking at whether Cluster randomised trial of a training and implementation programme of the NICE guideline across community mental health teams in SLaM can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Cluster randomised trial of a training and implementation programme of the NICE guideline across community mental health teams in SLaM and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: Department of Health
Condition: Schizophrenia

RecruitingISRCTN35852420

Neural correlates of response to COGnitive behaviour therapy in SCHIZophrenia: a functional magnetic resonance imaging investigation

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: King's College London (UK)
Condition: Schizophrenia

RecruitingISRCTN68736636

The European First Episode Schizophrenia Trial (EUFEST): Comparison of outcome in first episode schizophrenia with different low dose antipsychotic drug regimens

This study is testing a medication approach for people with Schizophrenia, schizophreniform, or schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years

Countries: Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Israel, Italy, Netherlands, Poland, Romania, Spain, Sweden, Switzerland
Sponsor: European Group for Research in Schizophrenia (EGRIS) (Austria)
Condition: Schizophrenia

RecruitingISRCTN46365995

Subjective well-being, craving for Cannabis and compliance or medication switch in a randomised double blind study with Olanzapine and Risperidone

This study is looking at whether questionnaires and follow-up can help people with Schizophrenia, schizo-affective disorder, schizofreniform disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherOver 18 Years

Countries: Netherlands
Sponsor: Academic Medical Centre (AMC) (The Netherlands)
Condition: Schizophrenia

RecruitingISRCTN27745631

Acetylsalicylic acid as an adjuvant therapy for schizophrenia

This study is looking at a support or therapy approach for people with Schizophrenia, schizo-affective disorder, schizofreniform disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.

SchizophreniaOtherOver 18 Years

Countries: Netherlands
Sponsor: University Medical Centre Utrecht (UMCU) (Netherlands)
Condition: Schizophrenia

RecruitingISRCTN81682255

Adherence therapy for people with schizophrenia in Suanprung Psychiatric Hospital, Thailand

This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOther

Countries: United Kingdom, Thailand
Sponsor: Praboromarajanok Institute of Workforce Development (Thailand)
Condition: Schizophrenia

RecruitingISRCTN42505388

The London East Anglia randomised controlled trial for cognitive-behaviour therapy for psychosis: effects of the treatment phase

This study is testing a medication approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN15904286

Comparison of intensive and standard case management programmes for psychotic patients

This study is looking at a support or therapy approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN44277627

The effectiveness of cognitive remediation therapy (CRT) for patients with schizophrenia

This study is looking at whether 1 can help people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in 1 and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN39441422

Randomised controlled effectiveness trial of a needs-based psychosocial intervention service for carers of people with schizophrenia

This study is looking at a support or therapy approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN51972256

Development and evaluation of personalised patient information for patients with schizophrenia living in the community.

This study is looking at whether Randomised trial with three groups: 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Randomised trial with three groups: 1 and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN14818560

A Randomised Controlled Trial of service level agreements between GPs and secondary services for the care of the long term mentally ill.

This study is looking at care and outcomes for people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to 1, but direct benefit is not guaranteed.

SchizophreniaOther

Countries: United Kingdom
Sponsor: Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN73679874

Brixton Early Psychosis Project

This study is looking at care and outcomes for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to 1, but direct benefit is not guaranteed.

SchizophreniaOther

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN42620357

A randomised controlled trial of cognitive therapy for command hallucinations

This study is looking at whether 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in 1 and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN43585723

Promoting personal recovery from psychosis: A randomised controlled trial in first episode schizophrenia

This study is looking at whether 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in 1 and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN35443116

Randomised Controlled Trial of Teaching Practice Nurses to Carry Out Structured Assessments of Patients Receiving Depot Antipsychotic Injections

This study is looking at whether 1 can help people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in 1 and complete follow-up assessments.

SchizophreniaOtherOver 18 Years

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN21277091

Randomised controlled trial of efficacy of teaching patients with bipolarity to identify early symptoms of relapse and obtain treatment

This study is looking at how 7 - 12 intervention treatment sessions from a research psychologist plus routine care versus routine care only works for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia in routine care. Participants take part in 7 - 12 intervention treatment sessions from a research psychologist plus routine care versus routine care only and complete follow-up assessments.

SchizophreniaOtherOver 18 Years

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN57116180

A randomised controlled trial of a computerised clinical decision support system for the management of psychiatric disorder in primary care.

This study is looking at whether questionnaires and follow-up can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Mental disorder, not otherwise specified. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherOver 16 Years

Countries: United Kingdom
Sponsor: Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN78915298

Evaluation of a carers' support programme

This study is looking at whether 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants take part in 1 and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN31813289

Increasing Access to Work for Longer Term Community Mental Health Team (CMHT) clients: the impact of a work-placement training intervention

This study is looking at whether 1 can help people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Mental disorder, not otherwise specified. Participants take part in 1 and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN37144448

Randomised controlled trial (RCT) to evaluate a patient-held shared record card for patients with long term mental illness

This study is looking at care and outcomes for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Scizophrenia. Direct benefit is not guaranteed, but the study may help researchers improve future care.

SchizophreniaOther

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN54567688

Acute effects of modafinil on cognitive function and activation of prefrontal cortex in people with schizophrenia

This study is looking at care and outcomes for people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOther

Countries: United Kingdom
Sponsor: Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN41543404

An international study of improving treatment for the most severely ill with schizophrenia

This study is looking at whether A double-blind, randomised controlled trial of risperidone compared to placebo augmentation will be carried out with 100 subjects can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in A double-blind, randomised controlled trial of risperidone compared to placebo augmentation will be carried out with 100 subjects and complete follow-up assessments.

SchizophreniaOther

Countries: United Kingdom
Sponsor: Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN72210184

A double-blind randomised controlled trial of repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of persistent auditory hallucinations in schizophrenia

This study is looking at whether a digital support tool can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in a digital support tool and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 65 Years

Countries: United Kingdom
Sponsor: Department of Health (UK)
Condition: Schizophrenia

RecruitingISRCTN01816159

Quality of Life following Adherence Therapy for People Disabled by Schizophrenia and their Carers

This study is looking at whether Patients will receive 8 sessions of either adherence therapy or health education delivered by a trained therapist in each of the five sites can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOther

Countries: United Kingdom, Germany, Italy, Netherlands
Sponsor: King's College London (UK)
Condition: Schizophrenia

Schizophrenia | Clinical Trials | HopeStage Research